The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
develop MS-based methods for in-depth interrogation of the proteome as well as for functional proteomics and apply these methods in cancer research. Our aim is to improve personalized cancer treatment by
-
to the advancement of personalized cancer therapies. What do we offer? A creative and inspiring environment full of expertise and curiosity. Karolinska Institutet is one of the world's leading medical universities
-
to the advancement of personalized cancer therapies. What do we offer? A creative and inspiring environment full of expertise and curiosity. Karolinska Institutet is one of the world’s leading medical universities
-
, including metabolomics, proteomics, and transcriptomics and use them to identify systems-level mechanisms in cancer to enhance treatment efficacy by uncovering new drug targets, biomarkers, and resistance
-
against cancer and contribute to groundbreaking research at the intersection of deep learning and cell biology, we encourage you to apply! Your profile To be eligible for employment as a postdoctor a
-
a better health for all. At Karolinska Institutet, we conduct successful medical research and hold the largest range of medical education in Sweden. As a doctoral student you are offered an individual
-
researchers at KTH and SciLifeLab. The doctoral student project and the duties of the doctoral student At the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet, we are looking
-
13 Apr 2024 Job Information Organisation/Company Karolinska Institutet (KI) Research Field Medical sciences Researcher Profile Recognised Researcher (R2) Country Sweden Application Deadline 2 May
-
13 Apr 2024 Job Information Organisation/Company Karolinska Institutet (KI) Research Field Medical sciences Researcher Profile Recognised Researcher (R2) Country Sweden Application Deadline 2 May
-
, including metabolomics, proteomics, and transcriptomics and use them to identify systems-level mechanisms in cancer to enhance treatment efficacy by uncovering new drug targets, biomarkers, and resistance